If a pill could turn back time and reverse ageing, it would be an incredible benefit to humanity. But can this be achieved without leading cells to become too young and cancerous?
Scientists at Harvard Medical School may have come close to discovering the Fountain of Youth with the discovery of chemical cocktails that rejuvenate senescent (older, degenerating) cells without altering or changing them permanently.
Scientists at Harvard Medical School have developed a chemical method for reversing cellular aging.
Scientists have achieved an amazing breakthrough, successfully reversing cellular aging in mice. A team led by Harvard Medical School researchers developed a chemical method for rejuvenating cells and returning them to a more youthful state, potentially revolutionizing treatments for age-related diseases and improving regenerative medicine while offering potential alternatives to gene therapy with lower development costs and shorter timelines.
This research builds upon earlier work by scientists, who demonstrated how Yamanaka factors — genes capable of turning adult cells into induced pluripotent stem (iPSC) cells — could reverse aging processes in various organs and tissues such as brain, kidneys, and muscles. Experiments even produced encouraging results including improved vision and longer lifespans among mice.
Early studies focused on just a few cells at a time, leading to many questions as to whether gene reprogramming would have the same impact on entire organs in real patients. To address this concern, this new study used an alternative approach by screening for chemicals that rejuvenate cells and restore their youthful phenotypes.
In their lab, the team tested thousands of chemicals to see which ones could reset chromatin structures and restore youthful gene expression patterns. Utilizing high-throughput cell-based assays and an automated aging clock, they measured each chemical’s effects on individual cells – ultimately leading them to identify six chemical cocktails that together could fully restore NCC and transcriptome aging in less than one week.
To validate their findings, scientists injected six chemical treatments into iPSCs from old mouse retinas and young controls respectively, finding that all six chemical treatments could restore them back to their youthful phenotypes without showing signs of unregulated cell growth.
Scientists then used this approach on various tissues and organs of lab animals, such as their eyes, skin, liver, and skeletal muscle. Sometimes their researchers were even able to completely reverse signs of aging such as improving vision in older mice or increasing lifespan – though it should be noted that such results require substantial funding in order to scale up into clinical trials.
The findings could revolutionize the treatment of aging and age-related diseases.
Goal setting may seem ambitious, but its rewards could be substantial. Aging-related diseases like heart disease, cancer and dementia remain the leading cause of death worldwide; and elderly deaths from such conditions tend to outnumber children and young adults by an overwhelming margin. Furthermore, these illnesses take years before being detected for diagnosis purposes.
Scientists have long been trying to find ways to combat ageing, using both ancient remedies and modern technological advancements as fuel for this quest. Now, however, we may finally be on the brink of discovering an anti-ageing formulation which restores youthfulness while prolonging health span.
But before we can put this theory into action, there is much work to do. A clinical trial that successfully reverses human aging would need to be designed and carefully tested in order to ensure its safety, show its efficacy in prolonging life, and treat multiple age-related illnesses at once with one chemical.
However, CAR T-cell therapy has attracted significant interest. One study used CAR T-cell therapy to remove senescent cells from mice’s bodies using CAR T-cell therapy, and discovered it reduced signs of ageing in their muscles and brains. CAR T-cell therapy may therefore offer promising strategies for treating age-related diseases by targeting specific regions with disease severity.
An alternative strategy involves taking a medication known as rapamycin, which has been found to slow the aging process and extend lifespan in rodents. It works by targeting the TOR pathway – involved in many biological processes that become disrupted as we age – which has already been approved for diabetes and rheumatoid arthritis treatments.
Researchers are exploring methods to reset cellular clocks using gene therapy. Last year, scientists from both countries reported reprogramming mature cells back into stem cells – which could potentially help repair damaged tissues but is far removed from reversing whole-body aging.
Recent research demonstrates that organs age differently between individuals, perhaps due to stress levels. Scientists hope that understanding individual organ aging rates could aid treatment for age-related diseases as well as extend human lifespan.
The research could lead to whole-body rejuvenation.
Searching for the Fountain of Youth has long been at the center of human endeavor. Thanks to advances in medical technology, many scientists now believe it may be possible to extend human lifespan and enhance overall health with proper research – however this must be designed and rigorously tested prior to use; additionally it must address causes behind age-related diseases which account for many deaths among older individuals.
Reversing aging could be achieved by turning senescent cells back into rejuvenative ones, and scientists have demonstrated this can be accomplished by expressing specific genes known as Yamanaka factors. This discovery marked an impressive feat and could eventually lead to therapeutic interventions for delaying or even reversing cell senescence, age-related pathologies, and diseases associated with age.
Reprogramming cells without pushing them too far backward, which could result in cancer, is key. Scientists have developed an alternative and safer method of reprogramming. By injecting AAVs containing genes for three Yamanaka factors into damaged retinal ganglion cells of mice eyes, regenerating retinal ganglion cells were seen regenerating as well as producing new axons that restored vision function to these animals.
Regenerative processes serve as the precursor for whole-body rejuvenation, an approach to restore the function of tissues and organs as a person ages. Reversing effects of aging at molecular level, while stimulating natural regenerative mechanisms within our bodies is part of this rejuvenation process.
As research into cellular reprogramming shows great promise of providing anti-ageing treatments, and lengthening human lifespan, billions will undoubtedly continue to flow into this technology from private equity funds and tech elite.
Some investors will likely continue spending money on longevity clinics run by CEOs like Bryan Johnson. It is essential that scientific community takes an objective approach when studying this research; human trials of reprogramming must first prove it works before chemical cocktails can be administered to patients without harming cells or increasing the risk of cancer or other harmful conditions.
The research is published in the journal Cell Reports
Scientists rely on journals as an avenue for disseminating their research and furthering knowledge. Cell Reports is one of the premier journals, publishing cutting-edge studies from across life science fields that contribute to multiple disciplines – evidenced by its high quality as proven by its impact factor, which measures importance and influence of scientific publications.
Cell Reports is dedicated to providing new biological insight for researchers working in various disciplines. Its broad array of content appeals to researchers with diverse interests, enabling cross-pollination of ideas and leading to groundbreaking discoveries. Alongside traditional articles, Cell Reports also publishes short-point stories and resources which focus on significant methodsological advances or major informational data sets.
All papers published in Cell Reports undergo thorough and transparent peer review prior to acceptance for publication. Any manuscript that describes human research using gametes or embryos (Category 2) and/or clinical trials must include an ethics statement which is reviewed by a bioethics expert either prior to or during peer review, to ensure all research involving humans meets stringent ethical standards.
Cell Reports takes pride in adhering to internationally-recognized ethical standards when publishing studies involving human subjects, adhering to both the World Medical Association’s Declaration of Helsinki and International Committee of Medical Journal Editors guidelines on reporting clinical research involving humans. This ensures all studies conducted involve humans are planned and conducted in accordance with internationally accepted ethical principles, thus producing reliable and impartial results.
At a time of digital disruption, academic journals are evolving the way scientists disseminate their findings. By adopting open access models, these journals are revolutionizing research dissemination and making more people eligible to benefit from cutting-edge science. Cell Press is committed to increasing accessibility through our gold open-access journal portfolio; authors may make their work freely accessible via Creative Commons licenses which offer an industry standard framework for reusing and sharing content.
The team plans to test whether its technique works on other animal models before exploring if it could reverse aging in humans, leading to the potential development of drugs that treat age-related illnesses and delay disability among older individuals.
